Singapore markets open in 7 hours 18 minutes
Straits Times Index
3,087.24 +10.08 (+0.33%) S&P 500
4,569.64 +2.46 (+0.05%) Dow
36,168.13 +43.57 (+0.12%) Nasdaq
14,249.54 +19.63 (+0.14%) Bitcoin USD
44,072.71 +714.36 (+1.65%) CMC Crypto 200
899.26 +656.58 (+270.55%)
AZN Jan 2024 75.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 02:07PM EST. Market open.
| Previous close | 0.0500 |
| Open | 0.0500 |
| Bid | 0.0300 |
| Ask | 0.0900 |
| Strike | 75.00 |
| Expiry date | 2024-01-19 |
| Day's range | 0.0500 - 0.0500 |
| Contract range | N/A |
| Volume | |
| Open interest | 3.08k |
- PR Newswire
Koselugo now available in Malaysia for paediatric patients with symptomatic neurofibromatosis type 1 (NF1) plexiform neurofibromas
AstraZeneca's Koselugo (selumetinib) is now available in Malaysia as a monotherapy for the treatment of paediatric patients three years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN)1. Koselugo, which received regulatory approval earlier this year, is a product approved by the National Pharmaceutical Regulatory Agency (NPRA) for NF1 with inoperable PN.
ZacksAstraZeneca PLC (AZN) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Astrazeneca (AZN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
ZacksAbsci (ABSI) Up on AstraZeneca Deal to Design New Cancer Therapy
Absci (ABSI) announces a collaboration agreement with AstraZeneca to develop an AI-designed antibody for an undisclosed oncology target. The stock rises 13%.
© 2023 Yahoo. All rights reserved.